Table 4.
The receiver operating characteristic curve analysis for diagnostic performance of contrast-enhanced ultrasound liver imaging reporting and data system LR-M characteristics in differentiation intrahepatic cholangiocarcinoma and LR-M hepatocellular carcinoma
| Criterion | AUC | 95%CI | Sensitivity(%) | 95%CI | Specificity (%) | 95%CI | +LR | 95%CI | -LR | 95%CI |
| Rim APHE | 0.7 | 0.63-0.76 | 70.4 | 58.4-80.7 | 68.8 | 60.9-75.9 | 2.3 | 1.9-2.7 | 0.4 | 0.3-0.7 |
| Early washout | 0.56 | 0.49-0.62 | 57.1 | 50.3-63.8 | 54.6 | 23.4-83.3 | 1.3 | 0.7-2.2 | 0.8 | 0.4-1.5 |
| Marked washout | 0.65 | 0.59-0.72 | 69.7 | 51.3-84.4 | 61 | 53.8-67.9 | 1.8 | 1.4-2.3 | 0.5 | 0.3-0.9 |
| Rim APHE + elevated CA 19-9 + normal AFP | 0.82 | 0.76-0.87 | 100 | 86.8-100 | 63.9 | 56.8-70.5 | 2.8 | 2.5-3.1 | - | - |
ROC: Receiver operator characteristic curve; AUC: Area under curve; ICC: Intrahepatic cholangiocarcinoma; HCC: Hepatocellular carcinoma; CA 19-9: Carbohydrate antigen 19-9; AFP: Alpha fetoprotein; CEUS: Contrast enhanced ultrasound; LI-RADS: Liver imaging reporting and data system; APHE: Arterial phase hyperenhancement; 95% CI: 95% confidence interval; +LR: Positive likelihood ratio; -LR: Negative likelihood ratio.